UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Review of precision cancer medicine: Evolution of the treatment paradigm

Cancer treatment reviews, 2020-06, Vol.86, p.102019-102019, Article 102019

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial design in the era of precision medicine

Genome medicine, 2022-08, Vol.14 (1), p.1-101, Article 101

2022

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3555-3561

2010

Link zum Volltext

Verfügbarkeit prüfen

Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (15), p.5081-5089

2011

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges

Frontiers in oncology, 2022-07, Vol.12, p.820128-820128

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

Cancer Immunology, Immunotherapy, 2022-02, Vol.71 (2), p.327-337

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes

Cancers, 2024-06, Vol.16 (13), p.2368

2024

Link zum Volltext

Verfügbarkeit prüfen

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects

Cancers, 2021-04, Vol.13 (9), p.2106

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer

PloS one, 2013-08, Vol.8 (8), p.e70429-e70429

2013

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer

PloS one, 2013-01, Vol.8 (1), p.e54048

2013

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer as a predominant feature in a patient with Peutz–Jeghers syndrome: Case report

Thoracic cancer, 2022-06, Vol.13 (12), p.1862-1865

2022

Link zum Volltext

Verfügbarkeit prüfen

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11834

2023

Link zum Volltext

Verfügbarkeit prüfen

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Data in brief, 2023-12, Vol.51, p.109698-109698, Article 109698

2023

Link zum Volltext

Verfügbarkeit prüfen

Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

Breast cancer (Tokyo, Japan), 2021-11, Vol.28 (6), p.1367-1382

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma

Cancers, 2021-01, Vol.13 (2), p.198

2021

Link zum Volltext

Verfügbarkeit prüfen

Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns

Diagnostics (Basel), 2024-06, Vol.14 (11), p.1076

2024

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Seminars in cancer biology, 2022-09, Vol.84, p.50-59

2022

Link zum Volltext

Verfügbarkeit prüfen

Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1634-1647

2021

Link zum Volltext

Verfügbarkeit prüfen

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

European journal of cancer (1990), 2023-08, Vol.189, p.112927-112927, Article 112927

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance

PloS one, 2010-04, Vol.5 (4), p.e9747-e9747

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(64)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Review of precision cancer medicine: Evolution of the treatment paradigm

Clinical trial design in the era of precision medicine

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges

Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer

Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer

Lung cancer as a predominant feature in a patient with Peutz–Jeghers syndrome: Case report

Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance

Suchergebnisse filtern